Management of JIA associated uveitis

This publication has 86 references indexed in Scilit:

• Optimizing the Start Time of Biologics in Polyarticular Juvenile Idiopathic Arthritis: A Comparative Effectiveness Study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans
  Arthritis & Rheumatology, 2021
• Temporal Relationship Between Juvenile Idiopathic Arthritis Disease Activity and Uveitis Disease Activity
  Arthritis Care & Research, 2020
• Imaging‐Based Uveitis Surveillance in Juvenile Idiopathic Arthritis: Feasibility, Acceptability, and Diagnostic Performance
  Arthritis & Rheumatology, 2020
• 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis
  Arthritis & Rheumatology, 2019
• Risk Factors and Biomarkers for the Occurrence of Uveitis in Juvenile Idiopathic Arthritis
  Arthritis & Rheumatology, 2018
• Identification of an Amino Acid Motif in HLA–DRβ1 That Distinguishes Uveitis in Patients With Juvenile Idiopathic Arthritis
  Arthritis & Rheumatology, 2018
• Anti–Interleukin‐6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis–Associated Uveitis Refractory to Anti–Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty‐Five Patients
  Arthritis & Rheumatology, 2017
• Abatacept for refractory juvenile idiopathic arthritis–associated uveitis: Two new cases. Comment on the article by Zulian et al
  Arthritis Care & Research, 2010
• Abatacept for severe anti–tumor necrosis factor α refractory juvenile idiopathic arthritis–related uveitis
  Arthritis Care & Research, 2010
• A randomized, placebo‐controlled, double‐masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis
  Arthritis Care & Research, 2005